StockData
Jade Biosciences, Inc. logo

Jade Biosciences, Inc. (JBIO) stock

JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$15.40+0.06 (+0.42%)

Close on Nov 17, 2026Market cap $979.40MP/E –Yield –

Jade Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Jade Biosciences

Jade Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jade Biosciences figures

See a number that looks wrong?